MARTY USSERY: Open Payments
NPI 1003540154 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $418 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $38 |
| ASAHI INTECC USA, INC. | 1 | $31 |
| TOLMAR, INC. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| COLOPLAST CORP | 1 | $15 |
Products named: ERLEADA, Asahi Peripheral Vascular Wires, JATENZO, GIVLAARI, XTANDI, GEMTESA, Coloplast TFL Drive.
Industry payments across NE — which companies pay providers there.
